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OBJECTIVES The goal of this study was to evaluate the safety and efficacy of surgical anterior ventricular
endocardial restoration (SAVER). The procedure excludes noncontracting segments in the
dilated remodeled ventricle after anterior myocardial infarction.
BACKGROUND Anterior infarction leads to change in ventricular shape and volume. In the absence of
reperfusion, dyskinesia develops. Reperfusion by thrombolysis or angioplasty leads to akinesia.
Both lead to congestive heart failure by dysfunction of the remote muscle. The akinetic heart
rarely undergoes surgical repair.
METHODS A new international group of cardiologists and surgeons from 11 centers (RESTORE group)
investigated the role of SAVER in patients after anterior myocardial infarction. From January
1998 to July 1999, 439 patients underwent operation and were followed for 18 months. Early
outcomes of the procedure and risk factors were investigated.
RESULTS Concomitant procedure included coronary artery bypass grafting in 89%, mitral valve (MV)
repair in 22% and MV replacement in 4%. Hospital mortality was 6.6%, and few patients
required mechanical support devices such as intraaortic balloon counterpulsation (7.7%), left
ventricular assist device (0.5%) or extracorporeal membrane oxygenation (1.3%). Postopera-
tively, ejection fraction increased from 29 6 10.4 to 39 6 12.4%, and left ventricular end
systolic volume index decreased from 109 6 71 to 69 6 42 ml/m2 (p , 0.005). At 18 months,
survival was 89.2%. Time related survival at 18 months was 84% in the overall group and 88%
among the 421 patients who had coronary artery bypass grafting or MV repair. Freedom from
readmission to hospital for congestive heart failure at 18 months was 85%. Risk factors for
death at any time after the operation included older age, MV replacement and lower
postoperative ejection fraction.
CONCLUSIONS Surgical anterior ventricular endocardial restoration is a safe and effective operation in the
treatment of the remodeled dilated anterior ventricle after anterior myocardial infarction.
(J Am Coll Cardiol 2001;37:1199–209) © 2001 by the American College of Cardiology
Myocardial infarction of the anterior wall leads to changes
in ventricular shape and size (1,2). Dramatic improvement
in regional left ventricular systolic function is not common
after reperfusion therapy (3). There is loss of contraction of
the anterior wall and septum. The remote muscle dilates as
an adaptive mechanism to maintain stroke volume. Ventric-
ular dysfunction occurs as a consequence of this remodeling
and may lead to congestive heart failure (CHF).
See page 1210
One large series examined the role of coronary artery
bypass grafting (CABG) alone among patients with poor
systolic function. Operative mortality was low and unrelated
to (EF). However, among patients with EF ,30%, five-
and eight-year survivals were 65% and 45%, respectively (4).
Another large study of CABG alone emphasized the im-
portance of ventricular volume as an additional predictor of
survival at five years. Patients with EF ,30% had a five-year
survival of 54% if the left ventricular end systolic volume
index (LVESVI) was .100 ml/m2. Among these survivors,
two-thirds had CHF (5).
Traditional surgical methods reduce volume only if a
dyskinetic scar is present. Surgical repair of the postinfarc-
tion dyskinetic dilated ventricle evolved from simple exci-
sion and closure (6) to Jatene’s septal exclusion (7). Volume
reduction was not considered for the akinetic segment. In
1984, Dor et al. (8) first recognized that the physiological
consequences of akinesia and dyskinesia were similar in their
adverse effect on global ventricular size and function. They
devised a surgical procedure in conjunction with CABG to
reduce ventricular volume. The operation reduces ventricu-
lar size by excluding the noncontracting segment with an
intraventricular patch. Dor’s procedure is applicable to both
morphologies (9,10). Survival at eight years, including
operative mortality in patients with severely depressed
ventricular function (EF , 30%), was 69% (11).
The importance of volume reduction in the prognosis of
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postinfarction patients with systolic dysfunction and ven-
tricular dilation has been established. A group was assem-
bled to verify Dor’s operative experience in multiple centers
and to assess intermediate clinical outcomes. The term
“restoration” refers to surgical methods that reverse patho-
logic left ventricular remodeling (12). Surgical anterior
ventricular restoration (SAVER) is an operation that re-
duces ventricular volume and utilizes Dor’s principles with
some technical modifications.
METHODS
Investigators. The Reconstructive Endoventricular Sur-
gery, returning Torsion Original Radius Elliptical Shape to
the LV (RESTORE) group (see Appendix for list of
participating investigators) is an international team of car-
diologists and surgeons from eleven institutions on four
continents. We examined the role of SAVER in postinfarc-
tion dilation.
Patient population. From January 1998 to July 1999,
RESTORE members performed SAVER in 439 patients
for postinfarction dilated cardiomyopathy. Median time
from infarction to operation was reported among 263
patients and was 564 days (25th percentile: 80 days, 75th
percentile: 2,487 days.) Age ranged from 25 to 89 years
(mean 63 6 10.7). Akinesia was seen in 64% of patients
(279 patients), dyskinesia in 33% (146 patients) and un-
stated in 3% (14 patients).
Variables included date of operation, concomitant proce-
dures including CABG, mitral valve (MV) repair or mitral
replacement, method of myocardial protection during the
restoration phase of the procedure (cardioplegia vs. open-
beating) and mechanical support modalities, including in-
traaortic balloon counterpulsation (IABP), left ventricular
assist device (LVAD) and extracorporeal membrane oxy-
genation (ECMO). Preoperative and postoperative EF and
LVESVI were measured. Postoperative New York Heart
Association functional class and rehospitalizations for CHF
were documented.
Surgical procedure. The SAVER portion of the operation
is performed immediately after CABG and MV repair or
replacement if indicated. During SAVER, the infarcted
anterior wall segment is incised parallel to the left anterior
descending artery. Internal inspection of the ventricle iden-
tifies scarred and viable myocardium. Transmural palpation
of contracting muscle precisely delineates the junction of
viable and nonviable tissue (Fig. 1). An encircling suture at
this junction excludes the scar from the ventricular cavity
and creates a pursed opening, usually about 2 by 3 cm (Fig.
2) (13). A dacron patch is secured onto this opening and
eliminates the akinetic or dyskinetic segment (Fig. 3).
Finally, the excluded scar is folded over the patch to assure
hemostasis (Fig. 4).
Dor’s patch insertion was described in the cardioplegia-
arrested heart. Some members of the RESTORE team
modified his myocardial protection method by using car-
dioplegia arrest during CABG/MV repair or replacement
followed by open-beating technique during patch placement
(14).
Statistics. Survival and freedom from rehospitalization
were estimated both nonparametrically (15) and parametri-
cally (16).
Univariable exploration of the association of variables
with respect to death or rehospitalization included chi-
square testing of frequency and Student t test for continuous
variables. Correlations were sought between variables. Life
tables stratified by categorical variables were compared by
the log-rank test. Calibration of continuous variables was
achieved by appropriate transformation of scale with the aid
of decile risk analysis. Interaction terms were formed to
identify differences in influence depending on myocardial
protection method.
A directed technique of stepwise entry of variables was
used (17). This was supplemented by bootstrap resampling,
whereby 1,000 random samples of the data were drawn with
replacement and an automated forward stepwise analysis
performed with a p value criterion for retaining variables of
0.05. The relative frequency of occurrence of variables in
these 1,000 models was used to inform the final selection of
variables (18). The p value criterion for retention of vari-
ables in the final models was 0.1. Regression coefficients are
presented 6 1 standard error.
The use of postoperative mechanical support was ana-
lyzed by logistic regression, using similar variable selection
techniques.
Means are presented 6 1 standard deviation. Confidence
limits (CL) of proportions, life table estimates and nomo-
grams for multivariable analyses are asymptotic equivalents
of one standard error.
RESULTS
Procedures. The SAVER procedure was carried out in all
439 patients. Concomitant CABG grafting was performed
in 89% of operations, while mitral repair was used in 22%
and mitral replacement in only 4%. Patients who underwent
MV repair or replacement had lower preoperative EF
(Fig. 5).
Efficacy of operation. Mean preoperative EF was 29 6
10.4% and increased postoperatively to 39 6 12.4% (p ,
Abbreviations and Acronyms
CABG 5 coronary artery bypass grafting
CHF 5 congestive heart failure
CL 5 confidence limits
ECMO 5 extracorporeal membrane oxygenation
EF 5 ejection fraction
IABP 5 intraaortic balloon counterpulsation
LVAD 5 left ventricular assist device
LVESVI 5 left ventricular end systolic volume index
MV 5 mitral valve
SAVER 5 surgical anterior ventricular restoration
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0.0001). Preoperative LVESVI, measured by ventriculogra-
phy, averaged 109 6 71 ml/m2 and decreased postopera-
tively to 69 6 42 ml/m2 (p , 0.0001), a reduction of 41 6
42 ml/m2 (Table 1). Normal LVESVI is 24 6 10 ml/m2
(19).
Myocardial protection. Multivariable analysis has not
shown a survival advantage with either type of myocardial
protection in the overall population. Hospital mortality was
15 of 233 patients after cardioplegia arrested restoration
(6.4%; CL: 4.8% to 8.6%) and was 14 of 204 (6.9%; CL:
5.0% to 9.2%) in patients receiving the open-beating tech-
nique (p 5 0.9). Time related survival has also been similar
(p 5 0.8).
Postoperative mechanical support. In 439 operations, a
small number of patients required IABP (7.7%), LVAD
(0.05) or ECMO (1.3%) support. Multivariable logistic
regression analysis showed that a concomitant MV repair/
replacement or a lower postoperative EF predicted the need
for support (Fig. 6). Preoperative EF did not predict the
need for support.
Intraaortic balloon counterpulsation use among patients
with preoperative EF ,30% was related to intraoperative
myocardial protection and suggests an advantage of the
open-beating method of protection. This technique was
used in one center during patch placement in 31 patients
(14,20). Average preoperative EF was 20% and LVESVI
Table 1. Left Ventricular Volume and Function
Variable n Mean 6 SD
Percentiles
Min 10 25 50 75 90 Max
Preoperative EF 411 29 6 10 6 15 20 29 35 43 64
Postoperative EF 354 39 6 12 9 24 30 40 48 55 75
Change in EF 349 11 6 11 220 22 4 10 18 25 42
Preoperative LVESVI 185 109 6 71 15 38 52 95 143 210 500
Postoperative LVESVI 191 69 6 42 5 23 36 61 97 125 225
Change in LVESVI 166 241 6 42 2275 287 254 232 215 24 39
EF 5 ejection fraction (%); LVESVI 5 left ventricular end systolic volume index (ml/m2).
Figure 1. The anterior ventricular scar (akinesia or dyskinesia) is opened and inspected. Palpation of the open-beating heart precisely delineates the margins
of contracting tissue. Reproduced with permission © 1999 Floyd E. Hosmer.
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Figure 2. An encircling suture separates the viable myocardium from scar and when tightened forms an oval platform onto which a patch can be secured,
usually 2 by 3 cm. Reproduced with permission © 1999 Floyd E. Hosmer.
Figure 3. The dacron patch is sewn into place either by mattressed interrupted sutures brought from outside of the ventricle to its interior or by an internal
continuous running stitch. Reproduced with permission © 1999 Floyd E. Hosmer.
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was 140 ml/m2. Aortic occlusion time during CABG or
mitral procedure averaged 87 min (range 60 to 140 min).
Patients were weaned off bypass with minimal drug support
(2.5 mg/kg/min dopamine), and only two patients required
IABP support.
Another center in the RESTORE group used crystalloid
cardioplegic arrest during CABG or mitral procedure through-
out patch placement in 88 patients. Mean EF was 20% and
LVESVI was 109 ml/m2. Substantial inotropic support (epi-
nephrine) and IABP use for low output were 15% and 40%,
with aortic occlusion times of 50 and 100 min respectively.
Survival. Overall hospital mortality among the 439 patients
was 6.6% (29 deaths). Mortality among 421 patients with
CABG or MV repair was 5.1%. It was higher among 18
patients with CABG or MV replacement (28%, p , 0.0001).
Follow-up at 18 months revealed 17 late deaths. The risk
of death was higher in the first month after operation but
rapidly declined thereafter to a level of 6.5% per year by
12 months. Overall survival was 89.2% at 18 months. Time
related survival was 84% at 18 months for the whole group
and 88% for the group with CABG or MV repair (Figs. 7
and 8).
Multivariate analysis identified incremental risk factors
for death at any time after operation. These included lower
postoperative EF (p , 0.0003), older age (p 5 0.01) and
concomitant MV replacement (p , 0.0001).
The influence of postoperative EF on 18-month survival
for a 60-year-old patient without MV replacement is shown
in Figure 9, which illustrates a more favorable outlook
among patients with a high EF. The combined influences of
advancing age and postoperative EF are shown in Figure 10.
If the postoperative EF is high, advancing age has little
impact on survival. However, if the postoperative EF is low,
survival decreases markedly with advancing age.
Concomitant MV replacement among 18 patients was
associated with a reduced survival (Fig. 8). Eight patients
underwent MV replacement in a center utilizing integrated
blood cardioplegia during CABG/MV replacement fol-
lowed by the open-beating method during patch placement.
The two deaths among these eight cases (25%) were not due
to low output syndrome. Despite relatively long aortic
occlusion times (mean 87 min, range 60 to 140 min), no
patient required IABP. By contrast, mortality was 30%
among ten patients undergoing MV replacement in centers
using cardioplegia-arrest during the entire operation and
was predominantly due to low output syndrome. Intraaortic
balloon counterpulsation was required in 30% to separate
from cardiopulmonary bypass.
Follow-up. Freedom from rehospitalization for CHF at 18
months after operation was 85%. Rehospitalization peaked
between two and four months and leveled to 8.8% per year
during the 18-month follow-up (Fig. 11). The risk of
Figure 4. The remaining akinetic or dyskinetic noncontracting scar is sewn over the patch and aids in hemostasis. Reproduced with permission © 1999
Floyd E. Hosmer.
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readmission was relatively insensitive to postoperative EF
until it was ,30%. (Fig. 12).
Among 277 patients for whom New York Heart Asso-
ciation functional class was reported, 36% were class I, 39%
class II, 21% class III and 3% class IV.
DISCUSSION
Ventricular dilation is an adaptive mechanism early after
infarction. It maintains stroke volume, but progressive
remodeling may become pathologic by its effect on the
remote noninfarcted myocardium (21). Myocyte hypertro-
phy and elongation develop with interstitial fibrosis, which
leads to an increasing mass without an increase in wall
thickness (eccentric hypertrophy) (22,23). Dilation also
distorts the normal fiber angle, which adversely affects
systolic torsion (24). Advanced enlargement leads to altered
ventricular shape and papillary muscle orientation that
restricts mitral leaflet coaptation producing regurgitation
Figure 5. Prevalence of performing a concomitant mitral valve procedure according to preoperative ejection fraction. Closed circles represent the observed
proportion of patients receiving a mitral valve procedure in roughly 10% increments in ejection fraction. The number of patients in each group is shown
for each dot. The solid line and its confidence limits are a trend line from logistic regression (p , 0.0001).
Figure 6. Prevalence of the need for post-SAVER mechanical support according to the level of postoperative ejection fraction and whether a mitral valve
procedure (repair or replacement) was performed. The depiction is a nomogram from the multivariable logistic regression analysis.
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(25). This may occur in experimental models even without
mitral annular enlargement (26).
Ventricular dilation is closely linked to risk of death after
infarction (27). Successful thrombolysis after infarction can
prevent or limit dilation but must occur within hours to
achieve significant myocardial salvage and prevent dilation
(28,29). The Global Utilization of Streptokinase and t-PA
for Occluded Coronary Arteries (GUSTO) I trial examined
the effect of early reperfusion on ventricular size using single
plane ventriculography at 90 and 180 min into thrombolytic
therapy for acute myocardial infarction. The authors found
that LVESVI .40 ml/m2 was associated with an increased
rate of hospital CHF and mortality at one year (30).
Gaudron et al. (31) studied patients three years after
infarction with successful reperfusion and found progressive
ventricular dilation in 20%.
Figure 7. Overall survival after the SAVER operation. Circles represent a death and are positioned on the horizontal axis at the time of the death and on
the vertical axis according to the Kaplan-Meier estimator. The vertical bars are asymmetric confidence limits equivalent to one standard error. The solid
line enclosed by dashed line confidence limits is the parametric survival estimate. The numbers at the foot of the graph represent the number of patients
still traced at three-month intervals.
Figure 8. Survival after the SAVER operation according to whether the mitral valve was replaced. In general, the format is as in Figure 3, with circles
representing patients who did not have mitral valve replacement (but may have had mitral valve repair) and squares representing patients with mitral valve
replacement. The numbers in parentheses along each curve represent the number of patients still traced beyond that point in time.
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Preoperative ventricular volume also predicts the progno-
sis in ischemic cardiomyopathy treated by CABG alone.
Yamaguchi et al. (5) observed patients with prior anterior
myocardial infarction with EF , 30%. At five years, CHF
occurred in 69% of patients with large ventricles
(LVESVI . 100 ml/m2) and in only 15% of patients with
smaller ventricles (LVESVI , 100 ml/m2). Mortality was
similarly affected, demonstrating 54% survival in patients
with large ventricles compared with 85% among patients
with smaller ventricles.
Surgical anterior ventricular restoration decreases wall
tension by reducing chamber size (Laplace’s law). It atten-
uates oxygen requirement of the remote muscle, improving
the oxygen supply/demand relationship. DiDonato et al.
(32) and Dor have shown that volume reduction by infarct
exclusion enhances regional systolic function in the myocar-
Figure 9. Nomogram of 18-month survival after the SAVER operation from the multivariable analysis of death. To construct this risk-adjusted depiction,
age at operation was set at 60 years, and mitral valve replacement was set to “no.” Note the expanded vertical axis. The solid line is the estimate, and the
dashed lines are the asymmetric confidence limits.
Figure 10. Nomogram of 18-month survival after the SAVER operation according to age and levels of ejection fraction from the multivariable analysis of
death. For this depiction, mitral valve replacement was set to “no.”
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dium remote from the anterior scar. An additional benefit of
volume reduction may be shape alteration, which realigns
muscle fiber orientation to allow optimal ejection (33).
The RESTORE group confirmed the feasibility of
operating on akinetic scars. Palpation of the open-beating
heart distinguished noncontracting akinetic segments that
did not collapse during ventricular decompression. Opera-
tive and late mortality was low. In this study, average
preoperative LVESVI of 109 ml/m2 was reduced to
69 ml/m2 postoperatively. After this significant volume
reduction, left ventricular systolic function improved.
Global EF increased from 29% to 39%. Mechanical support
use was uncommon (9%) despite poor preoperative systolic
function. At 18 months, 85% of discharged patients had not
been readmitted for CHF.
Study limitations. The primary intent of this registry was
to confirm Dor’s extensive experience and introduce sur-
geons to the concept of excluding the akinetic ventricle.
Although many surgeons used cardioplegia-arrest through-
out the procedure, others used the open-beating method of
Figure 11. Freedom from rehospitalization for chronic heart failure (CHF) after the SAVER operation. The format of the figure is as for Figures 3 and
4, except that the hazard function (instantaneous risk of rehospitalization for CHF) has been superimposed. It is scaled as % risk of rehospitalization per
year.
Figure 12. Nomogram of 18-month freedom from rehospitalization for chronic heart failure (CHF) according to postoperative ejection fraction. For this
risk-adjusted depiction, age was set at 60 years. The solid line is the point estimate, and the dashed lines are their confidence limits.
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protection during patch placement. Hence, the operations
were not precisely duplicated among centers.
Left ventricular end systolic volume index and EF were
not obtained in all patients. Follow-up measurements were
recorded in ambulatory patients between one and several
weeks postoperatively. All volumes were obtained by ven-
triculography; however, biplane methodology was not used
exclusively. Ejection fraction was calculated by echocardi-
ography or ventriculography. Although EF was calculated
by the same method for each patient before and after
operation, it was not obtained at precisely the same post-
operative interval.
Congestive heart failure evaluation was based on clinical
assessment alone and provided by the same observer for each
patient. The clinical criteria for readmission to the hospital
for CHF were not defined.
Patients were not randomized to medical therapy, CABG
alone, CABG/mitral procedures or a combination of these
procedures with SAVER.
Conclusions. Our multicenter experience in 439 patients
validates the safety and efficacy of SAVER and confirms
Dor’s single center experience in 835 patients with dilated
cardiomyopathy after anterior myocardial infarction (34).
Surgical anterior ventricular restoration is associated with
low operative mortality and infrequent use of mechanical
support. Survival at 18 months was encouraging and rehos-
pitalization for CHF was low.
The consequence of ventricular dilation after infarction is
detrimental. Our results support the need for randomization
of SAVER with medical therapy or CABG alone in
postinfarction dilated cardiomyopathy. Furthermore,
SAVER early after infarction may prevent late ventricular
dilation. The RESTORE group’s ongoing experience will
further define the indications and optimal methods of
restoration.
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